Running Against Prehypertension Trial (RAPT): A Pilot Trial
RAPT
1 other identifier
interventional
22
1 country
1
Brief Summary
This study will test strategies to help people with prehypertension adopt a running program to reduce their blood pressure in the long term. This study will be a 12 week intervention of about 40 participants randomized to running educational material, group based running instruction, or group based running instruction focused on form and all given the option to use the supplemental mHealth intervention. The purpose of this study is to collect feasibility, acceptability and preliminary efficacy data in preparation for a larger planned NIH-R01 study.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Mar 2012
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
March 1, 2012
CompletedFirst Submitted
Initial submission to the registry
March 29, 2012
CompletedFirst Posted
Study publicly available on registry
April 30, 2012
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 1, 2012
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2013
CompletedAugust 21, 2013
August 1, 2013
6 months
March 29, 2012
August 20, 2013
Conditions
Keywords
Outcome Measures
Primary Outcomes (3)
Feasibility of recruitment and retention
We will determine feasibility associated with recruitment n by recruiting and retaining at least 75% of our intended sample.
At the end of the 8 week recruitment period
Feasibility and acceptability of study protocol and materials
We will conduct both qualitative and quantitative analysis of the evaluations provided by participants to improve study protocol and materials and to indicate feasibility and acceptability of the study content. We will consider at least 75% of participants being "satisfied" or higher in the overall study evaluation to indicate acceptability of the study materials. We will consider completing at least 75% of the intended gait analyses and feedback from the lab specialists to indicate feasibility and a "satisfied" or higher score by at least 75% of participants as being acceptable.
At the end of the 12 week study
Preliminary efficacy data on changes in blood pressure
For the preliminary efficacy data we will compare systolic and diastolic blood pressure changes between baseline and post intervention to determine effect size to make sample size calculations for a larger planned trial.
Change in systolic and diastolic blood pressure from baseline at the end of the 12 week study
Secondary Outcomes (1)
Preliminary efficacy data on injury incidence
At the end of the 12 week study
Study Arms (3)
Educational materials control
OTHEREnhanced usual care
Group running style B
ACTIVE COMPARATORBasic running instruction using group based training.
Group running style A
EXPERIMENTALForm focused running instruction using group based training.
Interventions
Participants will be given educational materials on starting a running program using a run/walk approach.
Participants will attend a 4 hour group based training and 3, 2 hour follow up trainings.
Participants will attend a 4 hour group based training and 3, 2 hour follow up trainings.
Eligibility Criteria
You may qualify if:
- The target population for our proposed study is adults with upper range prehypertension defined by systolic blood pressure in the range of 130-144mmHg or diastolic blood pressure range in the range of 85-94mmHg.
- Potential participants will have two to three blood pressure screening measurements at least one day apart taken to screen for eligibility.
- Participants also must not be currently taking antihypertensive medications and must live in the San Francisco Bay Area.
You may not qualify if:
- Inability to provide informed consent
- Age \< 18 years
- Inability to run continuously for 5 minutes (required for the gait analysis)
- A substance or alcohol abuse, mental health, or medical condition that, in the opinion of investigators, will make it difficult for the potential subject to participate in the group intervention
- A history of cardiovascular disease or coronary artery disease including acute coronary syndrome, heart failure, severe aortic stenosis, acute infection or fever, or resting tachycardia (\> 100 bpm)
- A history of cardiac procedures including coronary artery bypass graft, angioplasty or stent placement.
- Typical or atypical angina
- Arrhythmia, alcoholism or other condition that makes accurate BP measurement difficult
- A diagnosis of diabetes, chronic kidney disease or other condition indicating medication for SBP \< 140mmHg
- Non-English speaking (group training will be given in English)
- Pregnant or planning to get pregnant during the study period
- Unwillingness or inability to commit to run/walking up to 30 minutes three times per week
- Plans to move from the San Francisco Bay area during the study time period
- Currently exercising at vigorous intensity for greater than 90 minutes per week. Vigorous intensity exercise may include race walking, jogging, running, hiking, swimming laps, or bicycling ≥ 10 miles per hour.
- BMI \> 30
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Osher Center for Integrative Medicine
San Francisco, California, 94115, United States
Related Publications (2)
McDermott K, Kumar D, Goldman V, Feng H, Mehling W, Moskowitz JT, Souza RB, Hecht FM. Training in ChiRunning to reduce blood pressure: a randomized controlled pilot study. BMC Complement Altern Med. 2015 Oct 15;15:368. doi: 10.1186/s12906-015-0895-x.
PMID: 26471194DERIVEDKumar D, McDermott K, Feng H, Goldman V, Luke A, Souza RB, Hecht FM. Effects of Form-Focused Training on Running Biomechanics: A Pilot Randomized Trial in Untrained Individuals. PM R. 2015 Aug;7(8):814-822. doi: 10.1016/j.pmrj.2015.01.010. Epub 2015 Jan 26.
PMID: 25633634DERIVED
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Kelly McDermott, PhD
University of California, San Francisco
- PRINCIPAL INVESTIGATOR
Fredrick Hecht, MD MPH
University of California, San Francisco
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- PREVENTION
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR
Study Record Dates
First Submitted
March 29, 2012
First Posted
April 30, 2012
Study Start
March 1, 2012
Primary Completion
September 1, 2012
Study Completion
June 1, 2013
Last Updated
August 21, 2013
Record last verified: 2013-08